Invivo Partners is a venture capital firm based in Barcelona, Spain, focusing on early-stage investments in biotechnology and deeptech sectors. Managed by Dr. Luis Pareras, Albert Ferrer, and Laura Rodríguez, the firm has invested in 17 portfolio companies and achieved four successful exits. Their portfolio companies have collectively raised over €450 million from global venture capital firms. Invivo Partners combines scientific, technical, and financial expertise to drive growth in the health sector, aiming to become a leading player in Europe's biotech industry. Their investor base includes major institutional investors such as the European Investment Fund, Instituto de Crédito Oficial (ICO), Institut Català de Finances (ICF), Institut Valencià de Finances (IVF), and the Barcelona City Council, alongside a majority of private investors.
Is Invivo Capital Partners the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Invivo Capital Partners, along with a list of other relevant VCs, is available on Hopohopo.io.
Investment role
Lead and follow
Stages
Pre-seed, Seed, Series A
First ticket size
€2,000,000 - €4,000,000
When reaching out to Invivo Partners, founders should highlight the scientific rigor and technical depth of their solution, demonstrating a clear path to clinical or technological validation. Emphasize the scalability of your innovation within the European health ecosystem and articulate how your team’s expertise aligns with the complex demands of biotech or deeptech commercialization. Show traction through early partnerships, regulatory milestones, or pilot results, and be prepared to discuss how additional capital will accelerate both product development and market entry.
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.